# FDA 483 - Hubei Kangzheng Pharmaceutical Co., Ltd. - June 24, 2024

Source: https://www.keypedia.com/records/483/hubei-kangzheng-pharmaceutical-co-ltd/a9e40004-e9a3-473c-bca4-b46842344916

> FDA 483 for Hubei Kangzheng Pharmaceutical Co., Ltd. on June 24, 2024. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hubei Kangzheng Pharmaceutical Co., Ltd.
- Inspection Date: 2024-06-24
- Product Type: other
- Office Name: Office of Health Technology 7 (In Vitro Diagnostics)
- Summary: The document content provided only contains page number references and does not include the actual text of an FDA 483 inspection report. Therefore, I am unable to extract information such as the company name, inspection dates, main violations, regulatory framework, or required actions to create a summary. To generate a summary, please provide the full text of the FDA 483 document.

## Related Documents

- [483 - 2021-06-21](https://www.keypedia.com/records/483/hubei-kangzheng-pharmaceutical-co-ltd/0166d972-1136-4524-adc9-b0eadf87c1ac)

## Related Officers

- [Supervisory Consumer Safety Officer, China Office](https://www.keypedia.com/people/marcus-a-ray/d394d757-5569-4697-bec1-c24113e29d6f)

Company: https://www.keypedia.com/companies/hubei-kangzheng-pharmaceutical-co-ltd/6dbf9b53-e225-4b9f-a956-869b8469c6dd

Office: https://www.keypedia.com/offices/office-of-health-technology-7-in-vitro-diagnostics/19bfc7ca-52e3-49b8-84a6-14d7fd927811